PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Longboard Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
PRICE T ROWE ASSOCIATES INC | 2,909,257 7.500% |
1,282,275 (+78.81%) |
Filing |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
PRICE T ROWE ASSOCIATES INC | 1,626,982 7.600% |
116,021 (+7.68%) |
Filing |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
PRICE T ROWE ASSOCIATES INC | 1,510,961 11.100% |
-513,655 (-25.37%) |
Filing |
| 2022-02-14 2:35 pm Sale |
2021-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
PRICE T ROWE ASSOCIATES INC | 2,024,616 14.900% |
-278,133 (-12.08%) |
Filing |
| 2021-04-12 2:07 pm Purchase |
2021-03-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
PRICE T ROWE ASSOCIATES INC | 2,302,749 17.300% |
2,302,749 (New Position) |
Filing |